These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9017685

  • 1. [Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs].
    Yokoyama T, Fujikura N, Masuda Y, Shikada K, Tanaka S.
    Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):307-21. PubMed ID: 9017685
    [Abstract] [Full Text] [Related]

  • 2. [Effect of efonidipine hydrochloride (NZ-105), a dihydropyridine derivative with calcium antagonistic action, on myocardial oxygen tension in anesthetized dogs].
    Fujikura N, Yokoyama T, Masuda Y, Shikada K, Tanaka S.
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):267-74. PubMed ID: 8974087
    [Abstract] [Full Text] [Related]

  • 3. Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
    Yokoyama T, Ichihara K, Abiko Y.
    Fundam Clin Pharmacol; 1997 Nov; 11(3):245-51. PubMed ID: 9243256
    [Abstract] [Full Text] [Related]

  • 4. [Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
    Fujikura N, Yokoyama T, Masuda Y, Shikada K, Tanaka S.
    Nihon Yakurigaku Zasshi; 1996 Aug; 108(2):39-48. PubMed ID: 8827722
    [Abstract] [Full Text] [Related]

  • 5. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina.
    Saito T, Fujii K, Takizawa T, Toyosaki T, Kuwabara Y, Kobayashi S, Ichikawa H, Karaki A, Yamazaki Y, Iwata J, Yamada K, Tomiya H, Takeda K, Inagaki Y.
    Arzneimittelforschung; 1996 Sep; 46(9):861-7. PubMed ID: 8876934
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M, Nagura J, Kamei K, Fukuroda T.
    Arch Int Pharmacodyn Ther; 1988 Sep; 291():7-20. PubMed ID: 3365068
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
    Sakanashi M, Noguchi K, Miyamoto Y, Kato T, Nagamine F, Yu WY, Higuchi M, Nakasone J.
    Arch Int Pharmacodyn Ther; 1988 Sep; 294():159-74. PubMed ID: 2976588
    [Abstract] [Full Text] [Related]

  • 10. Efonidipine, a long-acting dihydropyridine derivative, attenuates coronary vasoconstriction induced by endothelin-1 in dogs.
    Yokoyama T, Ichihara K, Abiko Y.
    Jpn J Pharmacol; 1996 Dec; 72(4):291-7. PubMed ID: 9015737
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y, Iwama T, Yamashita T, Sakai T, Hibi M, Tanaka S, Shigenobu K, Kasuya Y.
    Arch Int Pharmacodyn Ther; 1991 Dec; 314():57-73. PubMed ID: 1668604
    [Abstract] [Full Text] [Related]

  • 14. Coronary collateral blood flow in acute myocardial ischemia is not increased by dihydropyridine-induced coronary vasodilatation.
    Sjöquist PO, Duker G, Almgren O.
    J Cardiovasc Pharmacol; 1985 Dec; 7(4):630-6. PubMed ID: 2410700
    [Abstract] [Full Text] [Related]

  • 15. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs.
    Fischer G, Schneider W, Krumpl G, Grohs JG, Raberger G.
    Arch Int Pharmacodyn Ther; 1989 Dec; 298():96-107. PubMed ID: 2757470
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
    Uchida W, Shibasaki K, Asano M.
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of nisoldipine (Bay K 5552) on cardiovascular performance and regional blood flow in pentobarbital-anaesthetized pigs with or without beta-adrenoceptor blockade.
    Duncker DJ, Hartog JM, Hugenholtz PG, Saxena PR, Verdouw PD.
    Br J Pharmacol; 1986 May; 88(1):9-18. PubMed ID: 2871886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.